BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) Institutional Ownership and Insiders Activity

BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) is widely held by institutional investors, with 63 firms reporting positions valued at approximately $448.94M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Cormorant Asset Management, Lp is the largest disclosed holder, reporting approximately $136.23M in BBOT holdings in its latest filing.